In addition, we compare the expression levels of TME immunosuppressive variables, such as IL-10, TGF-β, Treg marker FOXP3, and cancer-associated adipocytes activated marker IL-6 (27), across the two risk groups. This evidence concerns the gene FOXP3 and cancer.